1. INTRODUCTION 1.1. OVERVIEW OF THE RADIOTHERAPY MARKET 1.2. MARKET SEGMENTATION & COVERAGE 1.2.1. CURRENCY AND PRICING 1.2.2. LIMITATION 2. RESEARCH METHODOLOGY 2.1. KEY TAKEAWAYS 2.2. ARRIVING AT THE RADIOTHERAPY MARKET SIZE 2.2.1. MARKET CRACKDOWN APPROACH 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS 2.2.3. DATA TRIANGULATION 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES 2.2.6. PORTER’S FIVE FORCES MATRIX 2.2.7. PEST ANALYSIS 2.2.8. EPIDEMIOLOGY FORECASTING MODELS 2.3. GLOBAL RADIOTHERAPY MARKET: RESEARCH SNAPSHOT 2.4. ASSUMPTIONS 3. MARKET LANDSCAPE SUMMARY 4. PREMIUM INSIGHTS 4.1. OVERVIEW 4.2. RADIOTHERAPY MARKET: KEY PRIMARY INSIGHTS 4.3. MARKET OVERVIEW 4.3.1. DRIVERS 4.3.2. RESTRAINTS 4.3.3. OPPURTUNITIES 4.3.4. THREATS 4.4. KEY MARKET FINDINGS 4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES 5. RADIOTHERAPY MARKET, BY THERAPY TYPE 5.1. OVERVIEW 5.2. BEAM RADIOTHERAPY 5.2.1. IMAGE-GUIDED RADIOTHERAPY (IGRT) 5.2.2. INTENSITY MODULATED RADIOTHERAPY (IMRT) 5.3.3. VOLUMETRIC MODULATED ARC THERAPY (VMAT) 5.3.4. TOMOTHERAPY 5.3.5. STEREOTACTIC TECHNOLOGY 5.3.6. 3D CONFORMAL RADIOTHERAPY 5.2. BRACHYTHERAPY 5.2.1. LOW DOSE RATE (LDR) 5.2.2. HIGH DOSE RATE (HDR) 5.4. SYSTEMIC RADIOTHERAPY 6. RADIOTHERAPY MARKET, BY PRODUCT TYPE 6.1. OVERVIEW 6.2. EXTERNAL BEAM RADIOTHERAPY EQUIPMENT 6.2.1. CYBERKNIFE 6.2.2. GAMMAKNIFE 6.2.3. LINAC 6.2.4. PROTON BEAM 6.2.4.1. CYCLOTRON 6.2.4.2. SYNCLOTRON 6.3. INTERNAL RADIOTHERAPY PRODUCTS 6.3.1. SEEDS 6.3.2. AFTERLOADERS 6.3.3. OTHERS 6.4. RADIOTHERAPY SOFTWARES 6.4.1. TREATMENT PLANNING SOFTWARES 6.4.2. DOSAGE PLANNING SOFTWARES 6.4.3. PATEINT POSITIONING SOFTWARES 6.4.4. IMAGE GUIDING SOFTWARES 6.5. SYSTEMIC RADIOTHERAPY 7. RADIOTHERAPY MARKET, BY INDICATION 7.1. OVERVIEW 7.2. BRAIN TUMOR 7.3. SPINE CANCER 7.4. LUNG CANCER 7.5. LIVER CANCER 7.6. BREAST TUMOR 7.7. PROSTRATE CANCER 7.8. OTHERS 8. RADIOTHERAPY MARKET, BY GEOGRAPHY 8.1. COUNTRYWISE RADIOTHERAPY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY) 8.1.1. NORTH AMERICA 8.1.1.1. U.S. 8.1.1.2. CANADA 8.1.1.3. MEXICO 8.1.2. EUROPE 8.1.2.1. GERMANY 8.1.2.2. FRANCE 8.1.2.3. U.K. 8.1.2.4. ITALY 8.1.2.5. SPAIN 8.1.2.6. RUSSIA 8.1.2.7. TURKEY 8.1.2.8. BELGIUM 8.1.2.9. NETHERLANDS 8.1.2.10. SWITZERLAND 8.1.2.11. REST OF EUROPE 8.1.3. ASIA-PACIFIC (APAC) 8.1.3.1. JAPAN 8.1.3.2. CHINA 8.1.3.3. SOUTH KOREA 8.1.3.4. INDIA 8.1.3.5. AUSTRALIA 8.1.3.6. SINGAPORE 8.1.3.7. THAILAND 8.1.3.8. MALAYSIA 8.1.3.9. REST OF APAC 8.1.4. LATIN AMERICA 8.1.4.1. BRAZIL 8.1.4.2. REST OF LATIN AMERICA 8.1.5. MIDDLE EAST AND AFRICA 8.1.5.1. SAUDI ARABIA 8.1.5.2. REST OF MIDDLE EAST AND AFRICA 8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES 9. RADIOTHERAPY MARKET: COMPETITIVE LANDSCAPE 9.1. GLOBAL RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS 9.2. NORTH AMERICA RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS 9.3. EUROPE RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS 9.4. APAC RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS 9.5. MERGERS & ACQUISITIONS 9.6. NEW PRODUCT DEVELOPMENT & APPROVALS 9.7. EXPANSIONS 9.8. REGULATORY CHANGES 9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 10. RADIOTHERAPY MARKET, COMPANY PROFILES 10.1. VARIAN MEDICAL SYSTEMS, INC. 10.1.1. OVERVIEW 10.1.2. SWOT ANALYSIS 10.1.3. PRODUCT PORTFOLIO 10.1.4. REVENUE ANALYSIS 10.1.5. ANALYSTS VIEW 10.2. CIVCO MEDICAL SOLUTIONS 10.2.1. OVERVIEW 10.2.2. SWOT ANALYSIS 10.2.3. PRODUCT PORTFOLIO 10.2.4. REVENUE ANALYSIS 10.2.5. ANALYSTS VIEW 10.3. ELEKTA AB 10.3.1. OVERVIEW 10.3.2. SWOT ANALYSIS 10.3.3. PRODUCT PORTFOLIO 10.3.4. REVENUE ANALYSIS 10.3.5. ANALYST VIEW 10.4. NANOBIOTIX 10.4.1. OVERVIEW 10.4.2. SWOT ANALYSIS 10.4.3. PRODUCT PORTFOLIO 10.4.4. REVENUE ANALYSIS 10.4.5. ANALYSTS VIEW 10.5. ACCURAY INCORPORATED 10.5.1. OVERVIEW 10.5.2. SWOT ANALYSIS 10.5.3. PRODUCT PORTFOLIO 10.5.4. REVENUE ANALYSIS 10.5.5. ANALYSTS VIEW 10.6. BRAINLAB AG 10.6.1. OVERVIEW 10.6.2. SWOT ANALYSIS 10.6.3. PRODUCT PORTFOLIO 10.6.4. REVENUE ANALYSIS 10.6.5. ANALYSTS VIEW 10.7. ION BEAM APPLICATIONS SA 10.7.1. OVERVIEW 10.7.2. SWOT ANALYSIS 10.7.3. PRODUCT PORTFOLIO 10.7.4. REVENUE ANALYSIS 10.7.5. ANALYSTS VIEW 10.8. C. R. BARD, INC. 10.8.1. OVERVIEW 10.8.2. SWOT ANALYSIS 10.8.3. PRODUCT PORTFOLIO 10.8.4. REVENUE ANALYSIS 10.8.5. ANALYSTS VIEW 10.9. ISORAY MEDICAL, INC. 10.9.1. OVERVIEW 10.9.2. SWOT ANALYSIS 10.9.3. PRODUCT PORTFOLIO 10.9.4. REVENUE ANALYSIS 10.9.5. ANALYSTS VIEW 10.10. TRF 10.10.1. OVERVIEW 10.10.2. SWOT ANALYSIS 10.10.3. PRODUCT PORTFOLIO 10.10.4. REVENUE ANALYSIS 10.10.5. ANALYSTS VIEW 10.11. NORDION, INC. 10.11.1. OVERVIEW 10.11.2. SWOT ANALYSIS 10.11.3. PRODUCT PORTFOLIO 10.11.4. REVENUE ANALYSIS 10.11.5. ANALYSTS VIEW 10.12. RAYSEARCH LABORATORIES AB 10.12.1. OVERVIEW 10.12.2. SWOT ANALYSIS 10.12.3. PRODUCT PORTFOLIO 10.12.4. REVENUE ANALYSIS 10.12.5. ANALYSTS VIEW 10.13. PRECISIS AG 10.13.1. OVERVIEW 10.13.2. SWOT ANALYSIS 10.13.3. PRODUCT PORTFOLIO 10.13.4. REVENUE ANALYSIS 10.13.5. ANALYSTS VIEW 10.14. MEVION MEDICAL SYSTEMS, INC. 10.14.1. OVERVIEW 10.14.2. SWOT ANALYSIS 10.14.3. PRODUCT PORTFOLIO 10.14.4. REVENUE ANALYSIS 10.14.5. ANALYSTS VIEW 10.15. MITSUBISHI ELECTRIC CORPORATION 10.12.1. OVERVIEW 10.12.2. SWOT ANALYSIS 10.12.3. PRODUCT PORTFOLIO 10.12.4. REVENUE ANALYSIS 10.12.5. ANALYSTS VIEW 11. APPENDIX 11.1. RELATED REPORTS 11.2. CUSTOMIZABLE OPTIONS 11.3. SOURCE SHEET 11.4. BIBLIOGRAPHY 12. ABOUT DATA BRIDGE MARKET RESEARCH